What is the current valuation of the halitosis treatment market in South Korea?

The market valuation was $97.8 Million in 2024. Read More

What is the projected market size for halitosis treatment in South Korea by 2035?

The projected valuation for 2035 is $294.0 Million. Read More

What is the expected CAGR for the halitosis treatment market during the forecast period 2025 - 2035?

The expected CAGR is 10.52% during the forecast period. Read More

What are the main segments of the halitosis treatment market in South Korea?

The main segments include indication, diagnostic tests, and drug treatment. Read More

What was the valuation of the gastrointestinal segment in 2024?

The gastrointestinal segment was valued at $20.0 Million in 2024. Read More

How much is the systemic segment projected to be valued by 2035?

The systemic segment is projected to reach $75.0 Million by 2035. Read More

What diagnostic tests are included in the halitosis treatment market?

Diagnostic tests include Halimeter, Gas Chromatography, BANA Test, and Β-Galactosidase Activity Assay. Read More

What was the valuation of antiseptics in the drug treatment segment in 2024?

Antiseptics were valued at $25.0 Million in 2024. Read More

What is the potential growth of the halitosis treatment market in South Korea?

The market appears to have substantial growth potential, with projections indicating a rise to $294.0 Million by 2035. Read More

South Korea Halitosis Treatment Market

Q: Which companies are the key players in the South Korean halitosis treatment market?

Key players include Procter & Gamble, Colgate-Palmolive, Unilever, Johnson & Johnson, GlaxoSmithKline, Church & Dwight, Henkel, and Listerine. Read More

ID: MRFR/HC/54788-HCR

200 Pages

Satyendra Maurya

Last Updated: February 06, 2026

South Korea Halitosis Treatment Market Research Report By Indication (Respiratory, Liver, Kidney, Gastrointestinal, Systemic, Others), By Diagnostic Tests (Halimeter, Gas Chromatography, BANA Test, -Galactosidase Activity Assay, Others) and By Drug Treatment (Antacids, Antiseptics, Ranitidine, Others) - Growth & Industry Forecast 2025 To 2035

South Korea Halitosis Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)10.52%

2024 Market Size$ 97.8 Million

2025 Market Size$ 108.09 Million

2035 Market Size$ 294 Million

Key Players

Procter & Gamble

Colgate-Palmolive

Unilever

Johnson & Johnson

GlaxoSmithKline

Church & Dwight

Trends

Rising Consumer Awareness
Preference for Natural Ingredients
Technological Advancements in Treatment

Opportunities

Increasing Oral Health Concerns
Rising Demand for Innovative Products
Growth of the Cosmetic Dentistry Sector

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Indication (USD Million)
  1. 4.1.1 Respiratory
  2. 4.1.2 Liver
  3. 4.1.3 Kidney
  4. 4.1.4 Gastrointestinal
  5. 4.1.5 Systemic
  6. 4.1.6 Others
2. 4.2 Healthcare, BY Diagnostic Tests (USD Million)
  1. 4.2.1 Halimeter
  2. 4.2.2 Gas Chromatography
  3. 4.2.3 BANA Test
  4. 4.2.4 Β-Galactosidase Activity Assay
  5. 4.2.5 Others
3. 4.3 Healthcare, BY Drug Treatment (USD Million)
  1. 4.3.1 Antacids
  2. 4.3.2 Antiseptics
  3. 4.3.3 Ranitidine
  4. 4.3.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Procter & Gamble (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Colgate-Palmolive (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Unilever (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 GlaxoSmithKline (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Church & Dwight (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Henkel (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Listerine (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY INDICATION
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY DIAGNOSTIC TESTS
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY DRUG TREATMENT
5. 6.5 KEY BUYING CRITERIA OF HEALTHCARE
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF HEALTHCARE
8. 6.8 DRIVERS IMPACT ANALYSIS: HEALTHCARE
9. 6.9 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 SUPPLY / VALUE CHAIN: HEALTHCARE
11. 6.11 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
12. 6.12 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
13. 6.13 HEALTHCARE, BY DIAGNOSTIC TESTS, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY DIAGNOSTIC TESTS, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY DRUG TREATMENT, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY DRUG TREATMENT, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY INDICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSTIC TESTS, 2025-2035 (USD Million)
  3. 7.2.3 BY DRUG TREATMENT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea South Korea Halitosis Treatment Market Segmentation

South Korea Halitosis Treatment Market By Indication (USD Million, 2025-2035)

Respiratory
Liver
Kidney
Gastrointestinal
Systemic
Others

South Korea Halitosis Treatment Market By Diagnostic Tests (USD Million, 2025-2035)

Halimeter
Gas Chromatography
BANA Test
Β-Galactosidase Activity Assay
Others

South Korea Halitosis Treatment Market By Drug Treatment (USD Million, 2025-2035)

Antacids
Antiseptics
Ranitidine
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”